Disrupted gut microecology after high-dose 131I therapy and radioprotective effects of arachidonic acid supplementation
ConclusionThese findings highlight that ARA, as a key metabolite, substantially contributes to radioprotection. Our study provides novel insights into the pivotal role that the microbiota-metabolite axis plays in radionuclide protection and offers effective biological targets for treating radiation-induced adverse effects.
Source: European Journal of Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Gastroenterology | Molecular Biology | Nuclear Medicine | Omega 6 | Study | Thyroid | Thyroid Cancer